FeesSafety
Pluang+

Merit Medical acquires Solo Pace for $45M, expanding cardiac therapies with innovative TAVR pacing tech.

Company Fundamentals
29 Oct 2026, 23:03 WIB
GlobeNewsWire
View Source
Bullish
Merit Medical acquires Solo Pace for $45M, expanding cardiac therapies with innovative TAVR pacing tech.

Merit Medical Systems has acquired Solo Pace, Inc. for approximately $45 million, gaining full ownership of the company that specializes in temporary pacing technology for transcatheter aortic valve replacement (TAVR) procedures. This acquisition enhances Merit's Cardiac Therapies platform with Solo Pace's SOLO PACE CONTROL™ and SOLO PACE FUSION™ systems, designed to simplify and improve the safety and efficiency of TAVR procedures. Merit had previously been the exclusive distributor of Solo Pace products and expects the acquisition to support growth and wider adoption of these technologies in the U.S. and globally. The acquisition is projected to be slightly accretive to Merit’s non-GAAP earnings in 2027 and accretive thereafter.

Merit Medical's acquisition of Solo Pace, Inc. provides context for health sector activity on Pluang. For readers following health stocks, 106 of 150 priced US health-sector stocks rose while 44 fell. Notable movers include TDOC at USD 8.74 with a 27.03% increase, ALNY at USD 177.80 down 23.49%, and INO at USD 0.77 down 17.07%. Data is as of Oct 30, 2026 03:11 WIB.

More News

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...

Company Fundamentals
Bullish
3 hours ago
Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...

Market News
Bearish
4 hours ago
Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token price increased by 3.00% within one hour on October 29, reaching $94.82 on Binance. Over the same 24-hour period, HYPE gained 17.28%, reflecting strong upward momentum. During this hour, significant liquidations occurred with...

Market News
Bullish
4 hours ago
Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson is currently trading at a high valuation of 27 times its earnings despite weak operating income and declining sales forecasts projected through 2027. Recent improvements in retail and inventory have not translated into sustainable ear...

Analyst Insights
Bearish
4 hours ago
$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

At least $5.57 billion in cryptocurrency was moved out of Binance-linked wallets across Ethereum, Bitcoin, and Tron blockchains in what appears to be a major security breach. Binance has not confirmed a hack but is actively investigating the potentia...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App